Robert Levak
Director/Board Member at Voxcell Bioinnovation, Inc.
Robert Levak active positions
| Companies | Position | Start | End |
|---|---|---|---|
Voxcell Bioinnovation, Inc.
 Voxcell Bioinnovation, Inc. Industrial MachineryProducer Manufacturing Voxcell Bioinnovation, Inc. is a Canadian company that creates solutions for the drug development industry and Oncology research. The company is based in Victoria, Canada. The company offers a range of products including Novel Bioinks, Truly Biomimetic Tissue Models for in vitro drug testing, and a unique super high resolution 3D Bioprinter. The company was founded by Karolina Valente and she has been the CEO since incorporation. | Director/Board Member | 01/06/2022 | - |
Phoenix Molecular Designs Ltd.
 Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | Director/Board Member | 01/03/2021 | - |
Career history of Robert Levak
Training of Robert Levak
| University of British Columbia | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Statistics
International
| Canada | 4 |
| United States | 2 |
Operational
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectoral
| Consumer Services | 3 |
| Producer Manufacturing | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Voxcell Bioinnovation, Inc.
Voxcell Bioinnovation, Inc. Industrial MachineryProducer Manufacturing Voxcell Bioinnovation, Inc. is a Canadian company that creates solutions for the drug development industry and Oncology research. The company is based in Victoria, Canada. The company offers a range of products including Novel Bioinks, Truly Biomimetic Tissue Models for in vitro drug testing, and a unique super high resolution 3D Bioprinter. The company was founded by Karolina Valente and she has been the CEO since incorporation. | Producer Manufacturing |
Phoenix Molecular Designs Ltd.
Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | Commercial Services |
- Stock Market
- Insiders
- Robert Levak
- Experience
